Page last updated: 2024-08-24

gemcitabine and shogaol

gemcitabine has been researched along with shogaol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jiang, L; Li, P; Ma, J; Qi, L; Xu, X; Zhou, L; Zhou, P	1

Other Studies

1 other study(ies) available for gemcitabine and shogaol

Article	Year
Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4/NF-κB signaling by 6-shogaol. The AAPS journal, 2014, Volume: 16, Issue:2 Topics: Animals; Antineoplastic Agents; Apoptosis; Catechols; Cell Line, Tumor; Deoxycytidine; Drug Synergism; Gemcitabine; Humans; Mice; NF-kappa B; Pancreatic Neoplasms; Signal Transduction; Toll-Like Receptor 4; Xenograft Model Antitumor Assays	2014

Article

Year

Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4/NF-κB signaling by 6-shogaol.

The AAPS journal, 2014, Volume: 16, Issue:2

Topics: Animals; Antineoplastic Agents; Apoptosis; Catechols; Cell Line, Tumor; Deoxycytidine; Drug Synergism; Gemcitabine; Humans; Mice; NF-kappa B; Pancreatic Neoplasms; Signal Transduction; Toll-Like Receptor 4; Xenograft Model Antitumor Assays

2014